Healthy Volunteers Clinical Trial
Official title:
The Effects of Eight Weeks of Virtual Training Based on Supersets vs. Concurrent Training on Muscle Strength, Cardiorespiratory Fitness, Motivation, Adherence, and HRQL in Women With Low to Moderate Levels of Physical Activity.
Verified date | July 2022 |
Source | Universidad de Antioquia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There are different forms of physical activity proven to improve muscular strength and cardiorespiratory fitness. One of them is concurrent training, which is defined as the combination of two or more physical capacities in the same session (resistance and endurance training). Another modality is superset training, which is characterized by performing two or more exercises for the same muscle group, or a different muscle group, consecutively, with minimal recovery between them. To date, the evidence has shown studies comparing different resistance training protocols, vs. aerobic training, and vs. concurrent training, performed in various ways, on muscle strength and cardiorespiratory fitness. Most of these studies involved men with resistance training experience, and little research linked women. It should be noted that no study found has used virtual training to test the effects of superset training compared to concurrent training in women with low to moderate levels of physical activity. Therefore, this study aims to identify the effect of a superset training program vs. a concurrent training program on muscle strength, cardiorespiratory fitness, motivation, adherence, and health-related quality of life in women with a low to moderate level of physical activity for eight weeks virtually.
Status | Completed |
Enrollment | 60 |
Est. completion date | June 30, 2022 |
Est. primary completion date | April 26, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility | Inclusion Criteria: - Healthy women - Physical activity (<600 to =1500 MET/min/wk) Exclusion Criteria: - Diabetes - Hypertension - History of cardiovascular disease - History of coronary heart disease - Osteoporosis - Pregnancy - Breast-feeding women - Psychological, neuromotor, and/or osteo-muscular conditions that may affect participation in an exercise program. |
Country | Name | City | State |
---|---|---|---|
Colombia | Universidad de Antioquia | Medellín | Antioquia |
Lead Sponsor | Collaborator |
---|---|
Universidad de Antioquia |
Colombia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in muscular strength | Test: One leg squat, leg lever, and push up. A maximum number of repetitions as possible to failure. | Baseline and 8-weeks | |
Secondary | Cardiorespiratory fitness | Queens College Step Test
The test consists of 3 minutes of stepping up and down on a 41.3 cm step at a set rate of 22 steps per minute for females and at 24 steps per minute for males. Estimation of VO2max can be calculated from the test results as follow: Men: VO2max(ml/kg/min) = 111.33 - (0.42 x heart rate (bpm) Women: VO2max(ml/kg/min) = 65.81 - (0.1847 x heart rate (bpm) |
Baseline and 8-weeks | |
Secondary | Health-related quality of life | Short Form 12 Health Survey (SF-12) Short Form 12 Health Survey (SF-12) Physical component score (PCS) 0-100 Mental component score (MCS) 0-100 The scores have a mean of 50 with a standard deviation of 10. Values above or below 50 indicate a better or worse state of physical or mental health. | Baseline and 8-weeks | |
Secondary | Motivation to exercise | Behavioural Regulation in Exercise Questionnaire-2 (BREQ-2). BREQ-2 has a Likert-type scale of 5 points, where 0 = not true for me and 4 = very true for me. | Baseline and 8-weeks | |
Secondary | Exercise adherence | Attendance at exercise sessions | Baseline and 8-weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |